An investigational medication is what is being studied to see if symptoms improve while taking it. It is not yet approved for general use by regulatory authorities. This study uses an investigational medication called Riliprubart. The investigational medicine is injected in a vein or under the skin, either at the …
This study investigates the effects of an investigational medication on adults with non-responsive celiac disease, where symptoms persist despite a gluten-free diet. This study aims to evaluate how the investigational medication affects changes in the intestinal lining compared to a placebo, focusing on the villous height to crypt depth ratio, …
This study investigates the efficacy and safety of an investigational medication in treating Systemic Lupus Erythematosus (SLE). Participants will be randomly assigned to one of two study arms: one receiving the investigational medication and the other receiving a placebo, which is an inactive substance that looks like the investigational medication …
This study investigates an investigational medication for adults with moderate to severe Crohn's Disease. The purpose of this study is to evaluate the efficacy and safety of different doses of the investigational medication compared to a placebo. A placebo is an inactive substance that looks like the investigational medicine/vaccine but …
This study investigates the effectiveness and safety of an investigational medication for adults diagnosed with IgG4-related disease (IgG4-RD). The purpose of this study is to compare the investigational medication to a placebo, which is an inactive substance that looks like the investigational medicine but does not contain any medicine, over …
This study investigates the effects of an investigational medication on individuals with warm autoimmune hemolytic anemia (wAIHA). The purpose is to compare the investigational medication with a placebo to determine its effectiveness and safety in improving hemoglobin levels in participants aged 18 and older with a confirmed diagnosis of primary …
This study investigates the effectiveness, safety, and tolerability of an investigational medication administered subcutaneously compared to a placebo in adults with high-risk asthma. This study is designed for adults between the ages of 18 and 80 who have asthma but are not eligible for biologic treatments.Participants in the study will …
